Regional differences in the effect of haloperidol and atypical neuroleptics on interstitial levels of DOPAC in the rat forebrain: An in vivo microdialysis study

Journal of Psychopharmacology

Volumn 10, Issue 2, 1996, Pages 119-125

  Fink Jensen, Anders ^a   Hansen, Liselotte ^a   Hansen, John Bondo ^a   Nielsen, Erik B ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

3,4 dihydroxyphenylacetic acid (DOPAC); Dorsolateral striatum; Microdialysis; Neuroleptics; Nucleus accumbens; Prefrontal cortex

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; SERTINDOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; FOREBRAIN; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

EID: 0029992430     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119601000206     Document Type: Article

References (36)

1. Andén N E, Grabowska-Andén M, Liljenberg B (1983) On the presence of autoreceptors on dopamine neurons in different brain regions. J Neural Transm 57: 129-137
2. Bannon M J, Roth R H (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35: 53-68
3. Bannon M J, Reinhard Jr J F, Bunney E B, Roth R H (1982) Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurons. Nature 296: 444-446
4. Benveniste H, Huttemeier P C (1990) Microdialysis - theory and application. Progr Neurobiol 35: 195-215
5. Borison R L, Diamond B I, Pathiraja A, Meibach R C (1992) Clinical overview of risperidone. In Meltzer H Y (ed.), Novel antipsychotic drugs. Raven Press, New York, pp. 233-239
6. Carlsson A, Lindquist M (1963) Effects of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140-144
7. Chen J, Paredes W, van Praag H M, Gardner E L (1992) Serotonin denervation enhances responsiveness of presynaptic dopamine efflux to acute clozapine in nucleus accumbens but not in caudate-putamen. Brain Res 582: 173-179
8. Chiodo L A, Bunney B S (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5: 2539-2544
9. Chiodo L A, Bannon M J, Grace A A, Roth R H, Bunney B S (1984) Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12: 1-16
10. Creese I, Burt D R, Snyder S H (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481-483
11. Drew K L, O'Connor W T, Kehr J, Ungerstedt U (1990) Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur J Pharmacol 187: 385-397
12. Essig E C, Kilpatrick I C (1991) Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala. Psychopharmacology 104: 194-200
13. Fink-Jensen A, Kristensen P (1994) Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neurosci Lett 182: 115-118
14. Galloway M P, Wolf M E, Roth R H (1986) Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J Pharmacol Exp Ther 236: 669-698
15. Hernandez L, Hoebel B G (1989) Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Brain Res Bull 22: 763-769
16. 1 receptors (ex vivo radiocepter binding studies) J Neural Transm 89: 61-69
17. Imperato A, Di Chiara G (1985) Dopamine release and metabolism in awake rats after systematic neuroleptics as studied by transstriatal dialysis. J Neurosci 5: 297-306
18. Invernizzi R, Morali F, Pozzi L, Samanin R (1990) Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Br J Pharmacol 100: 774-778
19. Kane J, Honigfeld G, Singer J, Meltzer H, The Clozaril Collaborative Study Group (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatr 45: 789-796
20. Karoum F, Egan M F (1992) Dopamine release and metabolism in the rat frontal cortex nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol. Eur J Pharmacol 105: 703-707
21. Leysen J E, Janssen P M F, Gommeren W, Wynants J, Pauwels P J, Janssen P A J (1992) In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone. Mol Pharmacol 41: 494-508
22. 2 receptors. Psychopharmacology 112: S40-S54
23. Livingstone M G (1994) Risperidone. Lancet 343: 457-460
24. Martin P T, Grebb J A, Schmitz P, Sebree T, Kashkin K (1994) Efficacy and safety of sertindole in double-blind, placebo-controlled trials of schizophrenic patients. Schizophrenia Res 11(2): 107 (abstract)
25. Meltzer H Y (1991) The mechanism of action of novel antipsychotic drugs. Schizophrenia Bull 17: 263-287
26. Meltzer H Y (1992) The mechanism of action of clozapine in relation to its clinical advantages. In Meltzer H Y (ed.), Novel antipsychotic drugs. Raven Press, New York, pp. 1-13
27. Moghaddam B, Bunney B S (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54: 1755-1760
28. Morgan J, Curran T (1989) Stimulus-transcription coupling in neurons: role of cellular immediate-early genes. Trends Neurosci 12: 459-462
29. Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717-719
30. Skarsfeldt T (1992) Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment. Synapse 10: 25-33
31. Sánchez C, Arnt J, Dragsted N, Hyttel J, Lembøl H L, Meier E, Perregaard J, Skarsfeldt T (1991) Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Devel Res 22: 239-250
32. Talmaciu R K, Hoffmann I S, Cubeddu L X (1986) Dopamine autoreceptors modulate dopamine release from the prefrontal cortex. J Neurochem 47: 865-870
33. Waldemeier P C, Maître L (1976) On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs. J Neurochem 27: 589-597
34. Weinberger D R (1988) Schizophrenia and the frontal lobe. Trends Neurosci 11: 367-370
35. Westerink B H C, Korf J (1976) Acidic dopamine metabolites in cortical areas of the rat brain: localization and effects of drugs. Brain Res 113: 429-434
36. Zetterström T, Sharp T, Ungerstedt U (1985) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106: 27-37